Literature DB >> 15078681

Stem cell therapy for ocular disorders.

Leonard A Levin1, Robert Ritch, Julia E Richards, Teresa Borrás.   

Abstract

Cell injury or degeneration occurs in a number of blinding diseases. Therapy has classically consisted of preventing the initial injury or increasing the resistance of cells to injury (cytoprotection). Recently, it has become possible to repopulate tissue compartments with stem cells. This article presents a current summary of ocular stem cell research and applications to disease. It is based on presentations and discussions from the July 2002 international conference "Stem Cells and Glaucoma" sponsored by the Glaucoma Foundation. This meeting, the first of its kind, brought together ophthalmologists, geneticists, immunologists, and developmental biologists working on stem cell development and applications in both human and animal models.

Entities:  

Mesh:

Year:  2004        PMID: 15078681     DOI: 10.1001/archopht.122.4.621

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

1.  Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy.

Authors:  Sowmya Parameswaran; Shashank Manohar Dravid; Pooja Teotia; Raghu R Krishnamoorthy; Fang Qiu; Carol Toris; John Morrison; Iqbal Ahmad
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

2.  Generation of Functional Human Retinal Ganglion Cells with Target Specificity from Pluripotent Stem Cells by Chemically Defined Recapitulation of Developmental Mechanism.

Authors:  Pooja Teotia; Divyan A Chopra; Shashank Manohar Dravid; Matthew J Van Hook; Fang Qiu; John Morrison; Angie Rizzino; Iqbal Ahmad
Journal:  Stem Cells       Date:  2016-10-26       Impact factor: 6.277

3.  A Co-culture Model for Determining the Target Specificity of the de novo Generated Retinal Ganglion Cells.

Authors:  Pooja Teotia; Matthew J Van Hook; Iqbal Ahmad
Journal:  Bio Protoc       Date:  2017-04-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.